Bhandari M, Pradhan A, Behera S, Singh AK. Coronary drug-coated balloons: Current evidence and emerging trends. World J Cardiol 2025; 17(12): 111468 [DOI: 10.4330/wjc.v17.i12.111468]
Corresponding Author of This Article
Akshyaya Pradhan, FACC, FCCP, FESC, Professor, Department of Cardiology, King George’s Medical University, Shahmina Road, Chowk, Lucknow 226003, Uttar Pradesh, India. akshyaya33@gmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Dec 26, 2025 (publication date) through Dec 24, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Bhandari M, Pradhan A, Behera S, Singh AK. Coronary drug-coated balloons: Current evidence and emerging trends. World J Cardiol 2025; 17(12): 111468 [DOI: 10.4330/wjc.v17.i12.111468]
Co-first authors: Monika Bhandari and Akshyaya Pradhan.
Author contributions: Pradhan A and Bhandari M conceived the project, prepared the first draft, performed the bibliography, and submitted the final manuscript; and they contributed equally to this manuscript and are co-first authors; Behera S and Singh AK performed the literature search and critically reviewed it.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Akshyaya Pradhan, FACC, FCCP, FESC, Professor, Department of Cardiology, King George’s Medical University, Shahmina Road, Chowk, Lucknow 226003, Uttar Pradesh, India. akshyaya33@gmail.com
Received: July 1, 2025 Revised: July 21, 2025 Accepted: November 4, 2025 Published online: December 26, 2025 Processing time: 177 Days and 9.3 Hours
Core Tip
Core Tip: Percutaneous coronary intervention has advanced rapidly over the past four decades. Despite significant progress in stent technology, there is still risk of late stent thrombosis and in-stent restenosis in long-term. Further improvement in percutaneous coronary intervention techniques/devices is imperative to achieve better outcomes. In recent years, drug-coated balloons have emerged as a viable alternative designed to overcome the limitations associated with drug-eluting stents. Drug-coated balloon leaves no residual metal inside coronary arteries and consequently suitable for an abridged antiplatelet regimen. They have demonstrated efficacy in the treatment of in-stent restenosis and can be useful in as small-vessel disease and diffuse lesions.
